Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(2.39) per share which missed the analyst consensus estimate of $(1.32) by 80.38 percent. This is a 2887.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $57.216 million which missed the analyst consensus estimate of $59.275 million by 3.47 percent. This is a 7.58 percent increase over sales of $53.185 million the same period last year.

• No comments yet. Be the first to comment!